Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Long-Term Investments (2024 - 2025)

BioAge Labs (BIOA) has disclosed Long-Term Investments for 2 consecutive years, with $100000.0 as the latest value for Q4 2025.

  • Quarterly Long-Term Investments changed 0.0% to $100000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $100000.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $100000.0 for FY2025, 0.0% changed from the prior year.
  • Long-Term Investments hit $100000.0 in Q4 2025 for BioAge Labs, roughly flat from $100000.0 in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $100000.0 in Q3 2024 to a low of $100000.0 in Q3 2024.